Paid Clinical Trials in Seattle, WA
As of September 2026, 1,284 paid clinical trials are recruiting in Seattle, Washington. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Seattle offers studies at sites including Seattle Children's Hospital for conditions such as Acute Myeloid Leukemia, Colorectal Cancer, Breast Cancer, Ovarian Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Seattle
Trials by drug in Seattle
Filter results
Newly added in Seattle
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Familial Inflammatory Bowel Disease Early Risk
KABAWIL: Reducing Intersectional Stigmas
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
1,156 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
A Study of Brenipatide in Participants With Opioid Use Disorder
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Top Research Study Locations in Seattle
Researchers run research studies in Seattle, WA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Seattle Children's Hospital | Diffuse Intrinsic Pontine Glioma, Cystic Fibrosis, High Grade Glioma | 184 |
| University of Washington | Amyotrophic Lateral Sclerosis, Spinal Cord Injuries, Multiple Myeloma | 183 |
| Fred Hutchinson Cancer Center | Breast Cancer, Acute Myeloid Leukemia, Colorectal Cancer | 141 |
| Fred Hutch/University of Washington Cancer Consortium | Acute Myeloid Leukemia, Hematopoietic and Lymphatic System Neoplasm, Stage IVB Prostate Cancer AJCC v8 | 104 |
| Swedish Medical Center-First Hill | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Malignant Solid Neoplasm | 66 |
| University of Washington Medical Center | Cystic Fibrosis, Heart Diseases, Heart Transplant | 50 |
| University of Washington Medical Center - Montlake | Prostate Adenocarcinoma, Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8 | 39 |
| Fred Hutchinson Cancer Research Center | Chronic Lymphocytic Leukemia, Advanced Solid Tumor, Chronic Graft-versus-host-disease | 36 |
| Swedish Cancer Institute | Breast Cancer, Endometrial Cancer, Chronic Lymphocytic Leukemia | 34 |
| Swedish Medical Center | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 32 |
| Virginia Mason Medical Center | Breast Cancer, Colorectal Cancer, Hearing Loss, Unilateral | 31 |
| Swedish Medical Center-Ballard Campus | Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm, Ovarian Carcinoma | 30 |
| Swedish Medical Center-Cherry Hill | Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm, Ovarian Carcinoma | 29 |
| Harborview Medical Center | Spinal Cord Injuries, Urothelial Carcinoma, Abdominal Aortic Aneurysms | 21 |
| VA Puget Sound Health Care System Seattle Division, Seattle, WA | Obesity, Adult Growth Hormone Deficiency, Advanced Urothelial Carcinoma | 20 |
| Seattle Children's | Suicidal Ideation, Acute Kidney Injury, Becker Muscular Dystrophy | 16 |
| FHCC at Northwest Hospital | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 14 |
| Fred Hutch Cancer Center | Colorectal Cancer, Advanced Adenocarcinoma, Astrocytoma, Grade IV | 11 |
| GSK Investigational Site | HIV Infections, Non-alcoholic Fatty Liver Disease, Gastrointestinal Neoplasms | 11 |
| VA Puget Sound Health Care System | Parkinson's Disease, Barrett's Esophagus, Carcinoma, Non-Small-Cell Lung | 11 |
| Benaroya Research Institute | Type 1 Diabetes Mellitus, Acute Pancreatitis, T1D | 9 |
| Seattle Children's Research Institute | ADA SCID, Adolescent Behavior, Brain Concussion | 8 |
| Seattle Clinical Research Center | Obesity, Overweight, Acute Migraine | 7 |
| Seattle Cancer Care Alliance | Acute Myeloid Leukemia, Breast Cancer, Chronic Myelomonocytic Leukemia | 6 |
| University of Washington - Harborview Medical Center | Aneurysm, Intracranial, Brain Aneurysm, CPAP | 6 |
Active & Upcoming Studies in Seattle (2026)
Recruiting trials in Seattle grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (486 active studies)
- Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · Phase 2 · National Cancer Institute (NCI)
- Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome · Phase 2 · Fred Hutchinson Cancer Center
Neurology & pain (62 active studies)
- COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE" · Phase 3 · Yale University
- Morphine or Ketamine for Analgesia · Phase 3 · Columbia University
Diabetes & metabolic (59 active studies)
- METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D) · Phase 2 · University of Washington
- Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS) · Phase 3 · Eli Lilly and Company
Cardiovascular (50 active studies)
- A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF) · Phase 2 · Edgewise Therapeutics, Inc.
- Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH) · Phase 2 · Stanford University
Mental health & behavior (28 active studies)
- VOCALE LBD: Online Peer Support for Caregivers of People With Lewy Body Dementia · University of Washington
- A Novel Smartphone Application for Helping Teens Stop Vaping, QuitQuest Vaping R01 · Fred Hutchinson Cancer Center
Pediatric (28 active studies)
- Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG). · Phase 2 · BrainChild Bio, Inc
- Mobile Technology to Reduce Teen Substance Misuse · Evidence-Based Practice Institute, Seattle, WA
HIV / STI (15 active studies)
- Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults · Seattle Institute for Biomedical and Clinical Research
- A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
Vaccines (12 active studies)
- A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age · Phase 3 · GlaxoSmithKline
- A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age · Phase 2 · ModernaTX, Inc.
Eye & vision (2 active studies)
- Disulfiram for Treatment of Retinal Degeneration · Phase 1, Phase 2 · University of Washington
- The Myelin Disorders Biorepository Project · Children's Hospital of Philadelphia
Common conditions studied in Seattle
- Acute Myeloid Leukemia (34 active studies)
- Colorectal Cancer (20 active studies)
- Breast Cancer (19 active studies)
- Ovarian Cancer (16 active studies)
- Prostate Cancer (14 active studies)
- Chronic Lymphocytic Leukemia (13 active studies)
Leading research sponsors in Seattle
- University of Washington
- Fred Hutchinson Cancer Center
- National Cancer Institute (NCI)
- Seattle Children's Hospital
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Seattle?
There are approximately 1,284 recruiting clinical trials in Seattle, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Seattle pay participants?
Most recruiting trials in Seattle compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Seattle?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Seattle?
The most common conditions under active study in Seattle include Acute Myeloid Leukemia (34), Colorectal Cancer (20), Breast Cancer (19), Ovarian Cancer (16), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Seattle?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Seattle on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Seattle?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Seattle?
Recruiting research sites in Seattle include Seattle Children's Hospital, University of Washington, Fred Hutchinson Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Seattle right now?
The largest active categories in Seattle are Cancer & tumors (486), Neurology & pain (62), Diabetes & metabolic (59). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.